Trade idea #BTK long on a break of the 5450 levelBiotechnology belongs to the sectors of the stock market which were rather moderately affected by the Coronacrisis. In fact, in the second half of april the NYSE ARCA Biotechnology Index even managed to surpass its pre-corona levels to attack its previous high at about 5.420. However the advance of the preceding days was too strong to get beyond that level and in line with the total market the index got rejeceted at that resistance level.
Looking now at the weekly chart a multi-month range between 3850 and 5450 can be seen which followed a previous advance of the index. Trend trader would now expect the index to pass the upper boundary of that range but we have to patiently wait if that will happen or if the index will continue to trade within that range.
For a long breakout trade the following trading strategies are possible:
a/ set a buy stop order > 5.550 (upper boundary at 5.450 + 2% )
b/ go long on a daily close > 5.450
c/ go long on a weekly close > 5.450 (unless price gets too far away from the 5450 handle)
d/ after a successfull breakout wait for a consolidation back to the 5450 level to look for a Long entry
Which strategy you use depends of course on your trading style. Also a combination of the 4 strategies could make sense, i.e. 33% for a/, 17% for b/, 17% for c/ and 33% for d/.
Stop loss should be the last swing low. If the index won't take out last week's low this would be 4.950, otherwise the stop must be adjusted.
A first target for 50% of the position could be set at the round figure of 7.000.
I will update on the trade idea. See you.
BTK trade ideas
Biotech symmetry. Let the market settle down, and then go long.The biotech sector is really interesting when you dive down into the symmetry of the last few cycles. Early 2000s-2008 and 2016-2018 are mini rallies within the bigger wedge. If this pattern is to continues, you can look for entry around the end of 2020 when we bump up against the larger support line (around $3600), and expect to hit the resistance of the larger wedge ($10,000). There is also a lot of confluence around the $7500 mark so we could fall back to that after hitting 10k. This would repeat this pattern for the third time.
Near term, I have some shorts in this sector because I think many of this small biotech companies have been operating at negative cash flow with a ton of free credit. I don't expect massive gains on these shorts, but I will certainly be going long towards the end of 2020.
Biotech Index big pictureA blowoff top is possible to around 7000. This happened during the last stage of a wave 3 of the same order.
Anyway the situation is getting riskier. There are signs of fatigue. The ascent is less steep, there is a divergence, fib relations would indicate a possible termination of the impuls right now, since wave 5 would be 76% of wave 3 and wave 1 is 0,24 % of wave 3, which would be ok.
The next correction might lead to around 3000.
Biotech: A Time Bomb About To ExplodeDefinition: The Bump and Run is a reversal pattern that forms after excessive speculation drives prices up too far, too fast.
The first phase is a uniform bullish trend with a trend line slope of 30 to 45 degree, then a period of excessive bullishness with a trend line slop of 50+ degrees, and finally the Run phase which is a period of sell-off.
I am looking for an major reversal in the u.s. indices, and especially the biotech, targeting the main lead in trend line.
Good luck , join me at twitter.com
Also at my Facebook page www.thefxchannel.com
My best regards,
Technician
Biotech BurstDefinition: The Bump and Run is a reversal pattern that forms after excessive speculation drives prices up too far, too fast.
The first phase is a uniform bullish trend with a trend line slope of 30 to 45 degree, then a period of excessive bullishness with a trend line slop of 50+ degrees, and finally the Run phase which is a period of sell-off.
I am looking for an initial down leg towards the bump red trend line, followed by the lead in orange trend line as a minimum target
Good Luck, Join me @:
twitter.com
thefxchannel.com
Past to Present XLF IBB QQQ SPYHere we are today. Financials breaking down and under performing. Biotech going parabolic. SPY and XLF is scaled left and Biotech index and QQQ scaled right. I think IBB will continue to run for a bit longer but any harsh snap in this industry will likely be similar to what happened in 2000s. Speculation will burst, and people will be running out the doors. Those that say that things are different need an intervention. They are in denial. Those that say theres no way this will play out will probably be left with the bag. BTW I'm long stocks and commodities, but net short after this week. Time will tell.. I really think biotech still has room to run for now, but watch the action
Blast from the Past IBB XLF QQQ SPY(1996-2002)We've heard that financials have led this rally too new highs and we need financials to continue to run. It isn't until institutions need to find more yield and start investing in speculative areas such as IPOs and Biotech (this should sound very familiar). This run on financials and SPY is amazing (scaled left) . Biotech and QQQ/COMP is just as impressive(scaled right). What happened after financials retested new highs and eventually underperforming biotech is what we should all fear most. This is the"dot com era", we shouldn't fear what tech is doing but how biotech has performed. Its about gaining more YIELD and outpeforming the previous year. We won't see a break in this market until biotech breaks. And my next chart is a tell tell sign of were i think we are. The correlation is pretty remarkable and shouldnt be ignored.